Literature DB >> 12821380

Aberrant trajectory of ascending dopaminergic pathway in mice lacking Nkx2.1.

Hitoshi Kawano1, Masao Horie, Shizuka Honma, Koki Kawamura, Kosei Takeuchi, Shioko Kimura.   

Abstract

In the embryonic brain, the transcription factor Nkx2.1 is localized in the medial ganglionic eminence and the ventromedial part of the hypothalamus. In the present study, we examined the development of mesencephalic dopamine (DA) neuron system in mice lacking Nkx2.1. In normal mice, tyrosine hydroxylase-immunoreactive axons from mesencephalic DA cells extended bilaterally in the lateral hypothalamus at embryonic day 12.5 (E12.5) and project to the ipsilateral striatum by E14.5. In the mutant brain, mesencephalic DA cell groups appeared to develop normally, but the majority of their ascending axons were observed to cross the ventral midline of the caudal hypothalamus and project to the contralateral striatum. DiI, a fluorescent dye, placed in the ventrolateral mesencephalon of E14.5 mutant mice, further revealed that majority of DiI-labeled axons projected to the contralateral striatum, while a minor ipsilateral projection was also observed. In the ventromedial hypothalamus of mutants, the neuroepithelium of third ventricle was missing, and immunoreactivity of semaphorin 3A, a soluble type of axon repellent, which was normally localized in the neuroepithelium, was remarkably reduced. Together with the recent evidence that the expression of slit2, another axon-repellent diffusible factor, is also eliminated in the hypothalamic neuroepithelium of Nkx2.1-deficient mice, the abnormal crossing of ascending DA axons observed may be attributed to the elimination of these chemorepulsive signals in the medial part of the mutant hypothalamus.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12821380     DOI: 10.1016/s0014-4886(03)00030-x

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  16 in total

1.  Expression by midbrain dopamine neurons of Sema3A and 3F receptors is associated with chemorepulsion in vitro but a mild in vivo phenotype.

Authors:  Enrique R Torre; Claire-Anne Gutekunst; Robert E Gross
Journal:  Mol Cell Neurosci       Date:  2010-03-16       Impact factor: 4.314

2.  High-resolution whole-genome association study of Parkinson disease.

Authors:  Demetrius M Maraganore; Mariza de Andrade; Timothy G Lesnick; Kari J Strain; Matthew J Farrer; Walter A Rocca; P V Krishna Pant; Kelly A Frazer; David R Cox; Dennis G Ballinger
Journal:  Am J Hum Genet       Date:  2005-09-09       Impact factor: 11.025

3.  The integrity of cholinergic basal forebrain neurons depends on expression of Nkx2-1.

Authors:  Lorenza Magno; Oliver Kretz; Bettina Bert; Sara Ersözlü; Johannes Vogt; Heidrun Fink; Shioko Kimura; Angelika Vogt; Hannah Monyer; Robert Nitsch; Thomas Naumann
Journal:  Eur J Neurosci       Date:  2011-11-18       Impact factor: 3.386

4.  Axonal growth regulation of fetal and embryonic stem cell-derived dopaminergic neurons by Netrin-1 and Slits.

Authors:  Ling Lin; Ole Isacson
Journal:  Stem Cells       Date:  2006-07-13       Impact factor: 6.277

Review 5.  Development and function of the midbrain dopamine system: what we know and what we need to.

Authors:  G B Bissonette; M R Roesch
Journal:  Genes Brain Behav       Date:  2015-11-08       Impact factor: 3.449

Review 6.  Axon guidance and synaptic maintenance: preclinical markers for neurodegenerative disease and therapeutics.

Authors:  Ling Lin; Timothy G Lesnick; Demetrius M Maraganore; Ole Isacson
Journal:  Trends Neurosci       Date:  2009-01-21       Impact factor: 13.837

7.  Wnt5a regulates midbrain dopaminergic axon growth and guidance.

Authors:  Brette D Blakely; Christopher R Bye; Chathurini V Fernando; Malcolm K Horne; Maria L Macheda; Steven A Stacker; Ernest Arenas; Clare L Parish
Journal:  PLoS One       Date:  2011-03-31       Impact factor: 3.240

8.  Development of posterior hypothalamic neurons enlightens a switch in the prosencephalic basic plan.

Authors:  Sophie Croizier; Clotilde Amiot; Xiaoping Chen; Françoise Presse; Jean-Louis Nahon; Jane Y Wu; Dominique Fellmann; Pierre-Yves Risold
Journal:  PLoS One       Date:  2011-12-16       Impact factor: 3.240

9.  Dopaminergic axon guidance: which makes what?

Authors:  Laetitia Prestoz; Mohamed Jaber; Afsaneh Gaillard
Journal:  Front Cell Neurosci       Date:  2012-07-31       Impact factor: 5.505

10.  A genomic pathway approach to a complex disease: axon guidance and Parkinson disease.

Authors:  Timothy G Lesnick; Spiridon Papapetropoulos; Deborah C Mash; Jarlath Ffrench-Mullen; Lina Shehadeh; Mariza de Andrade; John R Henley; Walter A Rocca; J Eric Ahlskog; Demetrius M Maraganore
Journal:  PLoS Genet       Date:  2007-06       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.